ArticleCureus2024
Autoimmune Hepatitis and Systemic Lupus Erythematosus Overlap Syndrome: A Case Report and Literature Review.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Cytopenias in Autoimmune Liver Diseases-A Review.Journal of clinical medicine · 2025Review
- HERV-K10 as a mediator of immune modulation in hepatitis infections.Frontiers in immunology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autoimmune hepatitis-systemic lupus erythematosus (AIH-SLE) overlap syndrome is a rare disease entity. In some cases, a delay in the occurrence of overlap is observed, where the diagnosis of one of the conditions precedes the other. However, other patients have features of both disorders simultaneously upon initial presentation, leading to a direct diagnosis of AIH-SLE overlap syndrome. Thus, the highly variable and non-specific clinical presentations of AIH-SLE overlap syndrome pose a diagnostic challenge that can only be overcome by maintaining a high index of suspicion. The best clinical practice involves the consideration of a wide list of differential diagnoses for each case, tailored toward its unique combination of symptoms and clinical findings. Although challenging, the timely establishment of an accurate diagnosis is crucial as even the etiologies sharing similar autoimmune pathophysiology demonstrate varying responses to the different therapeutic agents. This case report summarizes seven years of a middle-aged female's disease course, starting with her initial presentation, leading to her diagnosis with AIH, moving on to the establishment of overlap with SLE, and monitoring her response to the various treatment regimens she followed over the years. Despite trials of several recommended treatment regimens, the patient did not meet the requirements of remission for either AIH or SLE until the end of this observatory period. For the next steps in her management, several biological agents are under consideration as the existing scientific literature lacks recommendations specific to AIH-SLE overlap syndrome. This case report is intended to enrich the limited scientific literature pertaining to AIH-SLE overlap syndrome by documentation of this patient's individual disease course and review of the existing literature.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.